VON RICKENBACH JOSEF H purchased 304.5% of their position (47.06K shares) of REIN THERAPEUTICS, INC. on the open market
Open‑market purchase worth $49.6K — a major conviction buy. The strongest form of insider conviction signal.
P · 4 purchases
Filed: 5/29/2026ACC: 0001193125-26-245832
Director
Since Jun 2019
+47.06K
Net shares
Net buyer
$49.6K
Total acquired
4
Open market trades
4B · 0S
4
Total transactions
47.06K acquired
Non-Derivative Transactions4
Common stock , $0.001 par value
Direct
Shares
+3.42K
Price / share
$1.04
Trade value
$3.56K
% of position
22.1%
5/21/2026
15.45K→18.87K
Common stock , $0.001 par value
Direct
Shares
+15.95K
Price / share
$1.05
Trade value
$16.71K
% of position
84.5%
5/22/2026
18.87K→34.82K
Common stock , $0.001 par value
Direct
Shares
+23.19K
Price / share
$1.06
Trade value
$24.47K
% of position
66.6%
5/26/2026
34.82K→58.01K
Common stock , $0.001 par value
Direct
Shares
+4.50K
Price / share
$1.07
Trade value
$4.82K
% of position
7.8%
5/27/2026
58.01K→62.51K
Total
Net shares
+47.06K
Net value
$49.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock , $0.001 par value Direct | 5/21/2026 | P · Purchase | +3.42K | $1.04 | $3.56K | 22.1% | 15.45K | 18.87K |
| Common stock , $0.001 par value Direct | 5/22/2026 | P · Purchase | +15.95K | $1.05 | $16.71K | 84.5% | 18.87K | 34.82K |
| Common stock , $0.001 par value Direct | 5/26/2026 | P · Purchase | +23.19K | $1.06 | $24.47K | 66.6% | 34.82K | 58.01K |
| Common stock , $0.001 par value Direct | 5/27/2026 | P · Purchase | +4.50K | $1.07 | $4.82K | 7.8% | 58.01K | 62.51K |
| Total | +47.06K | $49.56K | ||||||
Derivative Transactions0
No derivative transactions reported